Castle Biosciences, Inc. · NASDAQ:CSTL
Juvenal Tobin W sold 19,040 Castle Biosciences, Inc. shares (Form 4)
Traded Jul 31 to Aug 3, 2026 · Filed Aug 4, 2026
From Jul 31 to Aug 3, 2026, Juvenal Tobin W (Chief Commercial Officer) sold 19,040 Castle Biosciences, Inc. shares at an average US$29.21 for US$556K under a trading plan, leaving 78,995 shares. Filed Aug 4, 2026 (Form 4).
- Sold
- 19,040 shares
- Price
- US$29.21 average (US$28.25 to US$30.26)
- Value
- US$556K
- Holding after
- 78,995 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | Common Stock | Sale | 8,149 | US$28.84 | 89,886 | Direct |
| Jul 31, 2026 | Common Stock | Sale | 7,270 | US$29.58 | 82,616 | Direct |
| Jul 31, 2026 | Common Stock | Sale | 1,891 | US$30.26 | 80,725 | Direct |
| Aug 3, 2026 | Common Stock | Sale | 1,730 | US$28.25 | 78,995 | Direct |
Source
Related
- Castle Biosciences, Inc.
- Juvenal Tobin W
- Castle Biosciences, Inc. shareholders
- Form 4 · Juvenal Tobin W · Oct 14, 2026
- Form 4 · Juvenal Tobin W · Oct 1, 2026
- Form 4 · Juvenal Tobin W · Sep 16, 2026
- Form 4 · Juvenal Tobin W · Sep 2, 2026
- Form 4 · Juvenal Tobin W · Aug 27, 2026
- Form 4 · Maetzold Derek J · Oct 7, 2026
- Form 4 · Oelschlager Kristen M · Oct 5, 2026
- Form 4 · Maetzold Derek J · Sep 23, 2026
- Form 4 · Maetzold Derek J · Sep 15, 2026
- Form 4 · Oelschlager Kristen M · Sep 3, 2026